JPMorgan Chase & Co’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Sell
934,023
-4,202,774
-82% -$4.75M ﹤0.01% 3688
2025
Q1
$7.5M Buy
5,136,797
+1,400,665
+37% +$2.04M ﹤0.01% 2386
2024
Q4
$7.96M Sell
3,736,132
-351,374
-9% -$748K ﹤0.01% 2418
2024
Q3
$11.4M Sell
4,087,506
-37,348
-0.9% -$105K ﹤0.01% 2076
2024
Q2
$9.61M Sell
4,124,854
-1,057,125
-20% -$2.46M ﹤0.01% 2138
2024
Q1
$23.2M Sell
5,181,979
-1,724,782
-25% -$7.71M ﹤0.01% 1594
2023
Q4
$22.2M Sell
6,906,761
-4,121
-0.1% -$13.2K ﹤0.01% 1570
2023
Q3
$21.9M Buy
6,910,882
+776,487
+13% +$2.46M ﹤0.01% 1450
2023
Q2
$30.5M Buy
6,134,395
+1,109,851
+22% +$5.52M ﹤0.01% 1275
2023
Q1
$24.8M Buy
5,024,544
+1,254,261
+33% +$6.2M ﹤0.01% 1339
2022
Q4
$23.7M Sell
3,770,283
-195,337
-5% -$1.23M ﹤0.01% 1318
2022
Q3
$42.8M Sell
3,965,620
-537,374
-12% -$5.8M 0.01% 1017
2022
Q2
$51.3M Buy
4,502,994
+945,877
+27% +$10.8M 0.01% 945
2022
Q1
$32.4M Sell
3,557,117
-66,162
-2% -$603K ﹤0.01% 1255
2021
Q4
$54.1M Buy
3,623,279
+301,479
+9% +$4.5M 0.01% 1052
2021
Q3
$85.4M Buy
3,321,800
+837,065
+34% +$21.5M 0.01% 873
2021
Q2
$64.8M Buy
2,484,735
+102,868
+4% +$2.68M 0.01% 1014
2021
Q1
$84.1M Buy
2,381,867
+424,778
+22% +$15M 0.01% 864
2020
Q4
$49.4M Buy
1,957,089
+269,173
+16% +$6.79M 0.01% 980
2020
Q3
$63.7M Buy
1,687,916
+277,470
+20% +$10.5M 0.01% 801
2020
Q2
$60.4M Buy
1,410,446
+1,022,462
+264% +$43.8M 0.01% 774
2020
Q1
$7.54M Buy
387,984
+303,747
+361% +$5.9M ﹤0.01% 1733
2019
Q4
$2.19M Buy
84,237
+71,479
+560% +$1.86M ﹤0.01% 2647
2019
Q3
$348K Buy
12,758
+2,063
+19% +$56.3K ﹤0.01% 3495
2019
Q2
$285K Buy
10,695
+5,303
+98% +$141K ﹤0.01% 3616
2019
Q1
$156K Sell
5,392
-112
-2% -$3.24K ﹤0.01% 3854
2018
Q4
$148K Buy
+5,504
New +$148K ﹤0.01% 3902